SUN vs VRTX · P/E 16, rev $22.69B vs P/E 30, rev $12.00B
Sunoco LP (SUN) versus Vertex Pharmaceuticals Inc (VRTX) — a side-by-side from cached financials, not a winner call.
Sunoco LP (SUN) is a oil & gas refining & marketing company listed on NYSE.
Vertex Pharmaceuticals Inc (VRTX) is a biotechnology company listed on US.
Latest reported SUN revenue for 2024-12-31 was $22.69B. Net income was $874.0M. Revenue was down 1.6% from 2023-12-31 to 2024-12-31. SUN currently screens at market cap $11.84B and trailing P/E 16.0.
Latest reported VRTX revenue for 2025-12-31 was $12.00B. Net income was $3.95B. Revenue was up 8.9% from 2024-12-31 to 2025-12-31. VRTX currently screens at market cap $106.87B and trailing P/E 29.7.
SUN currently screens at market cap $11.84B and trailing P/E 16.0. VRTX currently screens at market cap $106.87B and trailing P/E 29.7.
Not investment advice. Open the SUN and VRTX stock pages for the full models.
Not investment advice.